Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
2
×
clinical trials
life sciences
national blog main
national top stories
new york blog main
new york top stories
abbvie
acorda therapeutics
akcea therapeutics
alnylam pharmaceuticals
ampyra
apokyn
apomorphine
barry greene
biotech
boston
boston university
dalfampridine
dan ollendorf
drugs
duopa
fda
hereditary transthyretin amyloidosis
inbrija
inotersen
john berk
mary o'donnell
mylan
new york
parkinson's disease
patisiran
paul matteis
regeneron pharmaceuticals
rna interference
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
What
fda
friday
2
×
patients
2
×
acorda
ago
alnylam
approve
approved
awaits
biological
cope
crossed
decades
decision
discovered
disease
drug
episodes
fingers
gets
help
historic
late
looms
meant
medications
medicine
new
nod
parkinson’s
rival
rna
stop
time
treatment
trick
uses
working
Language
Current search:
patients
×
" boston top stories "
×
friday
×
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
